Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Exposure to Fine Particulate Air Pollution Causes Vascular Insulin Resistance by Inducing Pulmonary Oxidative Stress.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • المؤلفون: Haberzettl P;Haberzettl P; O'Toole TE; Bhatnagar A; Conklin DJ
  • المصدر:
    Environmental health perspectives [Environ Health Perspect] 2016 Dec; Vol. 124 (12), pp. 1830-1839. Date of Electronic Publication: 2016 Apr 29.
  • نوع النشر :
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • اللغة:
    English
  • معلومة اضافية
    • المصدر:
      Publisher: National Institute of Environmental Health Sciences Country of Publication: United States NLM ID: 0330411 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-9924 (Electronic) Linking ISSN: 00916765 NLM ISO Abbreviation: Environ Health Perspect Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: Research Triangle Park, N. C. National Institute of Environmental Health Sciences.
    • الموضوع:
    • نبذة مختصرة :
      Background: Epidemiological evidence suggests that exposure to ambient air fine particulate matter (PM2.5) increases the risk of developing type 2 diabetes and cardiovascular disease. However, the mechanisms underlying these effects of PM2.5 remain unclear.
      Objectives: We tested the hypothesis that PM2.5 exposure decreases vascular insulin sensitivity by inducing pulmonary oxidative stress.
      Methods: Mice fed control (10-13% kcal fat) and high-fat (60% kcal fat, HFD) diets, treated with 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPOL) or mice overexpressing lung-specific extracellular superoxide dismutase (ecSOD) were exposed to HEPA-filtered air or to concentrated PM2.5 (CAP) for 9 or 30 days, and changes in systemic and organ-specific insulin sensitivity and inflammation were measured.
      Results: In control diet-fed mice, exposure to CAP for 30 days decreased insulin-stimulated Akt phosphorylation in lung, heart, and aorta but not in skeletal muscle, adipose tissue, and liver and did not affect adiposity or systemic glucose tolerance. In HFD-fed mice, 30-day CAP exposure suppressed insulin-stimulated endothelial nitric oxide synthase (eNOS) phosphorylation in skeletal muscle and increased adipose tissue inflammation and systemic glucose intolerance. In control diet-fed mice, a 9-day CAP exposure was sufficient to suppress insulin-stimulated Akt and eNOS phosphorylation and to decrease IκBα (inhibitor of the transcription factor NF-κB levels in the aorta. Treatment with the antioxidant TEMPOL or lung-specific overexpression of ecSOD prevented CAP-induced vascular insulin resistance and inflammation.
      Conclusions: Short-term exposure to PM2.5 induces vascular insulin resistance and inflammation triggered by a mechanism involving pulmonary oxidative stress. Suppression of vascular insulin signaling by PM2.5 may accelerate the progression to systemic insulin resistance, particularly in the context of diet-induced obesity. Citation: Haberzettl P, O'Toole TE, Bhatnagar A, Conklin DJ. 2016. Exposure to fine particulate air pollution causes vascular insulin resistance by inducing pulmonary oxidative stress. Environ Health Perspect 124:1830-1839; http://dx.doi.org/10.1289/EHP212.
      Competing Interests: The authors declare they have no actual or potential competing financial interests.
    • Comments:
      Comment in: Environ Health Perspect. 2016 Dec 1;124(12 ):A236. (PMID: 27905277)
    • References:
      Circ Res. 2011 Mar 18;108(6):716-26. (PMID: 21273555)
      Am J Physiol Cell Physiol. 2010 Oct;299(4):C736-49. (PMID: 20554909)
      Environ Health Perspect. 2005 Jul;113(7):823-39. (PMID: 16002369)
      Circulation. 2004 Jan 6;109(1):71-7. (PMID: 14676145)
      Circulation. 2009 Feb 3;119(4):538-46. (PMID: 19153269)
      Diabetes Care. 2010 Oct;33(10):2196-201. (PMID: 20628090)
      J Asthma. 2009 Mar;46(2):207-9. (PMID: 19253132)
      Circulation. 2012 Feb 14;125(6):767-72. (PMID: 22219348)
      AAPS J. 2013 Oct;15(4):1001-11. (PMID: 23821353)
      J Clin Invest. 1999 Apr;103(7):1055-66. (PMID: 10194479)
      Circulation. 2004 Jun 1;109(21 Suppl 1):II27-33. (PMID: 15173060)
      Am J Physiol Heart Circ Physiol. 2009 May;296(5):H1586-97. (PMID: 19270193)
      Environ Health Perspect. 2007 May;115(5):709-14. (PMID: 17520057)
      Environ Health Perspect. 2008 Nov;116(11):1480-6. (PMID: 19057700)
      Diabetes. 2015 Mar;64(3):1011-24. (PMID: 25277399)
      Circulation. 2006 Apr 18;113(15):1888-904. (PMID: 16618833)
      Arterioscler Thromb Vasc Biol. 2010 Dec;30(12):2518-27. (PMID: 20864666)
      Sci Total Environ. 2011 Nov 1;409(23):4934-8. (PMID: 21925709)
      Toxicol Appl Pharmacol. 2013 Dec 15;273(3):551-60. (PMID: 24103449)
      Environ Health Perspect. 2015 May;123(5):381-9. (PMID: 25625876)
      J Leukoc Biol. 2010 Jul;88(1):33-9. (PMID: 20360405)
      J Infect Dis. 2009 Jul 15;200(2):279-87. (PMID: 19508161)
      Cell. 2010 Mar 19;140(6):900-17. (PMID: 20303879)
      Environ Health Perspect. 2012 Jun;120(6):848-56. (PMID: 22418586)
      Environ Health Perspect. 2010 Sep;118(9):1273-9. (PMID: 20504758)
      Circ Res. 2015 Jan 2;116(1):108-15. (PMID: 25348167)
      Arterioscler Thromb Vasc Biol. 2008 Nov;28(11):1982-8. (PMID: 18772497)
      World J Diabetes. 2015 Mar 15;6(2):326-32. (PMID: 25789114)
      Sci Total Environ. 2013 Mar 15;448:66-71. (PMID: 22901427)
      Toxicol Sci. 2011 Nov;124(1):88-98. (PMID: 21873646)
      PLoS One. 2014 Mar 11;9(3):e91639. (PMID: 24619127)
      Circulation. 2009 Feb 3;119(4):492-4. (PMID: 19188518)
      Environ Health Perspect. 2013 Jul;121(7):804-10. (PMID: 23632126)
      J Toxicol Environ Health B Crit Rev. 2012;15(1):1-21. (PMID: 22202227)
      Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):4882-7. (PMID: 9560197)
      Circulation. 2010 Jun 1;121(21):2331-78. (PMID: 20458016)
      Ann Epidemiol. 1999 Jul;9(5):290-6. (PMID: 10976855)
      N Engl J Med. 2007 Feb 1;356(5):447-58. (PMID: 17267905)
      Occup Environ Med. 2008 Jul;65(7):458-66. (PMID: 17989204)
      Am J Epidemiol. 2015 Mar 1;181(5):327-36. (PMID: 25693777)
      Clin Sci (Lond). 1997 Feb;92(2):147-52. (PMID: 9059315)
      J Biol Chem. 1996 Oct 18;271(42):26026-31. (PMID: 8824242)
      Curr Diab Rep. 2015 Jun;15(6):603. (PMID: 25894943)
      Cell Metab. 2011 Mar 2;13(3):294-307. (PMID: 21356519)
      Diabetes Care. 2013 Oct;36(10):3313-20. (PMID: 23780947)
    • Grant Information:
      P20 GM103492 United States GM NIGMS NIH HHS; R01 ES019217 United States ES NIEHS NIH HHS; R01 HL055477 United States HL NHLBI NIH HHS
    • الرقم المعرف:
      0 (Air Pollutants)
      0 (Antioxidants)
      0 (Cyclic N-Oxides)
      0 (Free Radical Scavengers)
      0 (Particulate Matter)
      0 (Spin Labels)
      EC 1.15.1.1 (Superoxide Dismutase)
      U78ZX2F65X (tempol)
    • الموضوع:
      Date Created: 20160430 Date Completed: 20170901 Latest Revision: 20220410
    • الموضوع:
      20221213
    • الرقم المعرف:
      PMC5132639
    • الرقم المعرف:
      10.1289/EHP212
    • الرقم المعرف:
      27128347